Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis
USA - English In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply MC2 Therapeutics and Almirall partner to make Wynzora® Cream a leading topical product for Plaque Psoriasis in Europe In a large European based Phase 3 clinical trial (n=490), Wynzora® Cream has demonstrated substantial efficacy with a PGA treatment success of 51% and beneficial treatment convenience[1] Marketing Authorization Application (MAA) in Europe of Wynzora® Cream has been filed and approval is expected this year
(1)
Transfer of technology from fusion to particle accelerators
ABINGDON, England, Feb. 17, 2021 /PRNewswire/ Tokamak Energy has entered a Collaboration and License Agreement with the Paul Scherrer Institute (PSI) for the use of Tokamak Energy s proprietary non-insulated high temperature superconducting (HTS) magnet technology for use in PSI s accelerator and beam line applications.
The magnet technology is based around the use of REBCO (Rare Earth Barium Copper Oxide) HTS tape and has been developed by Tokamak Energy as part of its mission to deliver fusion energy. These magnets have proved to be extremely robust and reliable and can be manufactured efficiently to high quality.
Iraq: Genel Energy announces update on oil reserves and resources
17 Feb 2021
Bill Higgs, Chief Executive of Genel, said: The quality of our reserves is the foundation of our resilient business model, providing us with low-cost production that can generate cash for many years to come. Drilling at Sarta this year has the potential to add to our reserves, with Qara Dagh adding the possibility of opening up another field in the Kurdistan Region of Iraq, as we look to further build our cash generative portfolio for the benefit of all stakeholders.
International petroleum consultants DeGolyer and MacNaughton assess that, at the
Russia: PetroNeft provides financing update
17 Feb 2021
AIM-listed
PetroNeft, an oil & gas exploration and production company, operating in the Tomsk Oblast, Russian Federation, and 50% owner and operator of
Licences 61 and 67, has provided a financing update.
Highlights
Loan facility
PetroNeft has entered into a convertible loan facility of US$2.9 million with a group of thirteen lenders that matures in March 2023.
The loan facility will be used for general corporate and ongoing operational purposes and carries an interest rate of 8% above the base rate of the Bank of England. Lenders can elect at any time to convert up to 75% of the outstanding loan to shares at a conversion price of stg£0.02 in year 1 and stg£0.025 in year 2.